Agios Pharmaceuticals
AGIO
#5052
Rank
โ‚ฌ1.38 B
Marketcap
23,82ย โ‚ฌ
Share price
1.13%
Change (1 day)
-59.18%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: โ‚ฌ1.38 Billion

As of December 2025 Agios Pharmaceuticals has a market cap of โ‚ฌ1.38 Billion. This makes Agios Pharmaceuticals the world's 5052th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ1.38 B-24.12%
2024โ‚ฌ1.83 B62.57%
2023โ‚ฌ1.12 B-21.72%
2022โ‚ฌ1.43 B-8.75%
2021โ‚ฌ1.57 B-35.4%
2020โ‚ฌ2.43 B-16.32%
2019โ‚ฌ2.91 B24.25%
2018โ‚ฌ2.34 B1.01%
2017โ‚ฌ2.32 B39.37%
2016โ‚ฌ1.66 B-25.53%
2015โ‚ฌ2.23 B-34.51%
2014โ‚ฌ3.41 B531.61%
2013โ‚ฌ0.54 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Agios Pharmaceuticals was reported to be:

โ‚ฌ1.38 Billion
by Nasdaq info icon info icon
โ‚ฌ1.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
โ‚ฌ1.06 B-23.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ10.25 B 638.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ127.11 B 9,052.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ8.81 B 534.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ83.93 B 5,943.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
โ‚ฌ777.90 B 55,909.63%๐Ÿ‡บ๐Ÿ‡ธ USA